|
| ORIGINAL ARTICLE |
|
| Year : 2014 | Volume
: 60
| Issue : 1 | Page : 7-11 |
Health-related quality of life in patients with chronic obstructive pulmonary disease in North India
H Negi1, M Sarkar2, AD Raval3, K Pandey4, P Das1
1 Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Hajipur, India
2 Department of Pulmonary Medicine, Indira Gandhi Medical College and Hospital, Shimla, India
3 Department of Pharmaceutical Systems and Policy, West Virginia University, Morgantown, West Virginia, USA
4 Department of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences, Indian Council of Medical Research, Patna, India
Correspondence Address:
H Negi
Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Hajipur
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0022-3859.128797
Background and Objectives: Chronic obstructive pulmonary disease (COPD) is a major health problem in India and constitutes an important cause of mortality and morbidity. A cross-sectional study was undertaken to assess health-related quality of life (HRQL) and its determinants in patients with COPD from India. Materials and Methods: A total of 126 patients (73.81% male) were enrolled using convenient sampling prospectively in this cross-sectional study. Eligible patients were assessed for socioeconomic status, anthropometric measures, COPD severity, dyspnea and health status using the Hindi version of St George's Respiratory Questionnaire (SGRQ). Linear regression model was used to examine the association between risk factors and HRQL score (a higher score indicating poorer HRQL), adjusting for age and sex. Results: The mean total score for SGRQ in the patients was 52.66 ± 12.89, indicating a marked impairment of HRQL. Impairment was associated with the severity of airway obstruction, but within each Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage, the variation (SD) was wide [stage I: 47.8 ± 12.3 (n = 14); stage II: 49.28 ± 11.69 (n = 47); stage III: 53.47 ± 11.69 (n = 44); stage IV: 61.75 ± 14.14 (n = 21)]. A regression analysis showed that body mass index, forced expiratory volume in 1 s (FEV 1 ), dyspnea grade, and depression were associated with poor HRQL. Conclusion: HRQL of COPD patients was significantly impaired across stages. Marked impairment of HRQL was found even in patients with mild disease.
[FULL TEXT] [PDF]*
|
